69 results
Page 2 of 4
8-K
EX-1.1
4mkbemilz 2y
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am
424B4
l066vtudb3t23
11 Oct 22
Prospectus supplement with pricing info
8:27am
8-K
d85nkod8jfdf08
25 May 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
EX-1.1
bfbyg6d2
13 Dec 21
Entry into a Material Definitive Agreement
9:23am
424B5
i0j8j hra
13 Dec 21
Prospectus supplement for primary offering
9:19am
424B5
q6ekhzpm
10 Dec 21
Prospectus supplement for primary offering
5:25pm
CORRESP
9vq32xs
9 Dec 21
Correspondence with SEC
12:00am
424B5
rc2t1l
10 Nov 21
Prospectus supplement for primary offering
5:25pm
8-K
EX-1.1
u14 2r1bf
10 Nov 21
Entry into a Material Definitive Agreement
5:22pm
424B5
ltcn3va
9 Nov 21
Prospectus supplement for primary offering
5:14pm